Fresenius Kabi


Global Healthcare Company Invests $250 Million in Illinois

Fresenius Kabi, a Germany-based manufacturer of pharmaceuticals, is expanding its presence in Illinois with a $250 million state-of-the-art campus outside of Chicago.

The larger, modernized facility, which will be complete in 2020, will allow the drug maker to boost production of injectable medicines that are currently in high demand in the United States.

The company has more than 2,500 U.S. employees, 60 percent of which are based in Illinois.

Quick Facts
Employees in Illinois
Quick Facts
$250 Million
Contact Us

Brent Case

Senior Vice President,
Business Development

312-667-6013 brent.case@intersectillinois.org LinkedIn Profile